Ovarian Cancer section

Ovarian Cancer News & Features

Low-Dose Aspirin May Lower Ovarian Cancer Risk

Low-Dose Aspirin May Lower Ovarian Cancer Risk

Inverse association for low-dose but not standard-dose aspirin with ovarian cancer risk.

Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer

Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer

The use of anti-inflammatory analgesics, such as aspirin, may extend survival for patients with ovarian cancer.

Adding Bevacizumab to First-line Chemotherapy Benefits Selects Cases of Ovarian Cancer

Adding Bevacizumab to First-line Chemotherapy Benefits Selects Cases of Ovarian Cancer

Researchers conducted a retrospective analysis to determine the impact of inflammatory responses in patients with ovarian cancer undergoing first-line chemotherapy with or without bevacizumab.

Link Between Asbestos-Free Talcum Powder and Cancer Unclear

Link Between Asbestos-Free Talcum Powder and Cancer Unclear

Studies conducted in people have mixed results, with some indication of increased risk of ovarian cancer.

FDA-Approved Ovarian Cancer Drug Treatments

FDA-Approved treatment options for individuals with ovarian cancer including dosing.

Long-Term Benefits Seen With Trabectedin With PLD for Recurrent Ovarian Cancer

Long-Term Benefits Seen With Trabectedin With PLD for Recurrent Ovarian Cancer

Researchers conducted a prospective real-life analysis to determine the effects of trabectedin plus PLD in patients with platinum-sensitive recurrent ovarian cancer.

Are Ovarian Cancer Stem Cells the Target for Innovative Immunotherapy?

Are Ovarian Cancer Stem Cells the Target for Innovative Immunotherapy?

[OncoTargets and Therapy] In a review of cancer stem cells (CSCs)/ovarian cancer stem cells (OCSCs), researchers discuss the implications of immunotherapy development based on studying cancer evolution by CSCs, and targeting OCSC surface markers to develop CAR-T immunotherapy.

Severe Folate Deficiency Associated With Olaparib for Relapsed Ovarian Cancer

Severe Folate Deficiency Associated With Olaparib for Relapsed Ovarian Cancer

In a case study, olaparib was found to induce folate deficiency in most patients with relapsed ovarian cancer. Researchers discuss the significance of this adverse effect and how it was managed.

Primary Cytoreductive Surgery for HGSC Offers Better Survival Than Neoadjuvant Chemotherapy

Primary Cytoreductive Surgery for HGSC Offers Better Survival Than Neoadjuvant Chemotherapy

Researchers conducted a retrospective cohort analysis to examine patterns of clinical practice in the management of women with advanced HGSC.

Rucaparib Granted FDA Approval for Some Recurring Abdominal Cancers

Rucaparib Granted FDA Approval for Some Recurring Abdominal Cancers

The US FDA granted approval based on results from ARIEL3, a randomized clinical trial conducted with 561 eligible cancer patients.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs